A national alliance of families, the pharmaceutical industry, patients, consumer groups, and drug abuse prevention advocates in the USA has released a nation-wide strategy proposal to counter the continued rise in prescription drug abuse.
"Rising rates of prescription drug abuse are the result of a combination of factors and can only be countered successfully by a coordinated, multi-sector strategy," said Michael Barnes, executive director of CLAAD, the Center for Lawful Access and Abuse Deterrence. The CLAAD's National Prescription Drug Abuse Strategy, co-written with the Human Resources Development Institute, advocates a balanced public policy approach.
Abuse second only to marijuana
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze